Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1991
03/27/1991CA2026090A1 Anthelmintics
03/27/1991CA2026038A1 4-substituted 2-aminoalk-3-enoic acids
03/27/1991CA2026037A1 Anthelmintics
03/26/1991WO1991004479A1 Evaluative means for detecting inflammatory reactivity and for predicting response to stress
03/26/1991WO1991004048A1 Therapeutic agent and method of inhibiting vascularization of tumors
03/26/1991WO1991004029A1 Orally administered porphyrins to control intestinal iron absorption
03/26/1991US5003098 Administering a Myo-Inositol Triphosphate
03/26/1991US5003080 Process for trans-6-(2-(substituted-pyrrol-1-yl)alkyl)pryan-2-one inhibitors of cholesterol synthesis
03/26/1991US5003073 Process for producing cephalosporin antibiotics, and novel intermediates for use in such process and their production
03/26/1991US5003072 Viricides
03/26/1991US5003061 Crystallization of lactulose from a solution of lactulose by seeding
03/26/1991US5002974 Anesthetic/skin moisturizing composition and method of preparing same
03/26/1991US5002973 Stabilized sulfite-free catecholamine compositions
03/26/1991US5002972 Compound and composition of substituted hexenoic acid derivatives useful for treating thromboxane A2 mediated diseases
03/26/1991US5002970 Flavor masked ionizable zinc compositions for oral absorption
03/26/1991US5002969 Pharmaceutical compositions containing titanocene complexes and use of these complexes as cytostatic agents
03/26/1991US5002968 Organogermanium compound, calcium metabolism
03/26/1991US5002967 Phenolic thioethers, sulfoxides, and disulfides as inhibitors of 5-lipoxygenase
03/26/1991US5002966 Adrenergic Stimulants
03/26/1991US5002965 Plant extracts for preservation of living tissues, cells or organs
03/26/1991US5002963 Central Nervous System Disorders
03/26/1991US5002962 Porphyrins
03/26/1991US5002961 Antiischemic Agents, Preventing Reperfusion Injuries
03/26/1991US5002960 N-haloalkyl-4-(isoxazol-5-yl)alkoxy benzamides
03/26/1991US5002959 Antitumor agents, fungicides
03/26/1991US5002958 Hypotensive agent
03/26/1991US5002956 Use of heterocyclic compounds for iontophoretic treatment
03/26/1991US5002954 Leukemia, melanoma
03/26/1991US5002953 Novel compounds
03/26/1991US5002952 Benzoylurea Antitumor Agents
03/26/1991US5002948 Central Nervous System Disorders
03/26/1991US5002946 Gastrointestinal diseases associated with smooth muscle contractions
03/26/1991US5002945 Imidazole derivatives
03/26/1991US5002943 Condensed diazepinones, processes for preparing them and pharmaceutical compositions containing these compounds
03/26/1991US5002941 Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
03/26/1991US5002940 Solid drug formulations and stable suspensions
03/26/1991US5002939 Inhibit cell growth
03/26/1991US5002938 Fungicide, Steroid, Alcohol and Diol and/or Triol Solvent, Hydroxyalkyl Cellulose
03/26/1991US5002937 Diphosphonic acid compounds and use for calcium metabolism disorders
03/26/1991US5002935 Inclusion Complexing Hydroxypropylcyclodextrin with a Dihydropyridine-substituted Drug
03/26/1991US5002930 Protein absorption enhancing agents
03/26/1991US5002879 Treatment of tumors with autologous LAK cells, interleukin-2 and an ornithine decarboxylase inhibitor
03/26/1991US5002776 Multilayer polymeric membrane
03/26/1991US5002774 Sustained release pharmaceutical tablet
03/26/1991US5002773 Transdermal delivery of (+) (2S,3S)-3-acetoxy-8-chloro-5-(2-dimethylaminoethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4-(5H)-one
03/26/1991US5002769 Compositions for the sustained-release of chlorhexidine
03/26/1991US5002767 Therapeutic composition containing alpha-linolenic acid and a compound capable of promoting the passage of the acid through the cell membrane, plant extract comprising the acid and the compound, and process for the preparation of the extract
03/26/1991US5002759 Containing fucose and/or galactose, mouthwashes, chewing gum
03/26/1991US5002756 Method for relieving radiogenic or drug-induced side effects
03/26/1991US5002755 Administering A Dithiocarbamate Chelator
03/26/1991US5002753 Z Isomers, Halovinyl Substituents
03/26/1991CA2067123A1 Evaluative means for detecting inflammatory reactivity and for predicting response to stress
03/26/1991CA2025958A1 Substituted 2-amidotetralins as melatonin agonists and antagonists
03/26/1991CA2025820A1 Pyrimidoindole derivatives and processes for preparation thereof
03/26/1991CA2025479A1 6-and/or 7-substituted-1,2,3,4,4a 9b-hexahydro-8-hydroxydibenzofuran-3-ols as inhibitors of leukotriene biosynthesis
03/26/1991CA2025478A1 Trans 2,3-disubstituted-2,3-dihydro-5-hydroxybenzofurans as inhibitors of leukotriene biosynthesis
03/26/1991CA1282077C Process for producing substituted-phenethylamine derivatives
03/26/1991CA1282072C 1-styrene sulfonyl 2-oxo 5-hydroxy pyrrolidine derivatives, process and intermediates for their preparation, use as medicaments and compositions therefrom
03/26/1991CA1282071C Indole derivatives, process for their preparation, their use to fight pests,and compounds containing said derivatives
03/26/1991CA1282065C Antihypertensive agents comprising 2- alkynyladenosines as active ingredients
03/26/1991CA1282064C Macrolide compounds
03/26/1991CA1282062C Quaternary ammonium salts of natural polysaccharides possessing hypocholesterolemic activity
03/26/1991CA1282060C Tetrahydro-3,4-furandiamine-n,n'-platinum complexes
03/26/1991CA1282059C Macrolide antibiotic derivatives
03/26/1991CA1282008C Rapid acting intravenous emulsion of omega-3 fatty acid esters
03/26/1991CA1282007C Formulations containing azole derivatives, and their use for atraumatic nail removal
03/26/1991CA1282006C Infusion solutions of 1-cyclopropyl-6-fluoro-1,4-dihydro 4-oxo-7-(1-piperazinyl)-quinoline-3- carboxylic acid
03/26/1991CA1282005C Antiglaucoma compositions and process for their preparation
03/26/1991CA1282004C Inactivation of bacterial endotoxins
03/26/1991CA1282002C Pharmaceutical composition comprising t-pa and oxypurinol
03/26/1991CA1281936C Anticoccidial compositions
03/24/1991CA2025968A1 Substituted 1,3,4-oxa(thia)diazolinones process for their preparation and their use of combating endoparasites
03/23/1991CA2025967A1 Pyridone nitriles useful in treating cardiovascular disease
03/23/1991CA2025860A1 Amino acid derivatives
03/23/1991CA2025849A1 Benzimidazole compounds and their use
03/23/1991CA2025731A1 Phenylalkyl amine derivatives having antiischaemic activity
03/23/1991CA2024421A1 Prodrugs of carbonic anhydrase inhibitors
03/22/1991WO1991004058A2 Treatment of conditions and disease
03/22/1991CA2042034A1 Treatment of conditions and disease
03/22/1991CA2025930A1 Phenothiazine derivatives, process for their preparation and pharmaceutical compositions containing the same
03/22/1991CA2025830A1 Pyrrolopyrimidines, their production and use
03/22/1991CA2025799A1 Pyrimidine-4,6-dicarboxylic acid diamides, processes for their preparation and the use thereof, and pharmaceuticals based on these compounds
03/22/1991CA2025763A1 Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form
03/22/1991CA2024282A1 Heterocyclic hydrazide derivatives of monocyclic beta-lactam antibiotics
03/21/1991WO1991004259A1 Lipid a monosaccharide analog
03/21/1991WO1991003544A1 Novel hydrolytic enzyme inhibitors and substrates and assays, methods and kits embodying same
03/21/1991WO1991003512A1 Cytoprotective fatty moiety compounds
03/21/1991WO1991003495A1 Method for producing soluble glucans
03/21/1991WO1991003467A1 Benzazabicyclic carbamates as novel cholinesterase inhibitors
03/21/1991WO1991003247A1 Dosage form for administering oral hypoglycemic glipizide
03/21/1991WO1991003245A1 Ophthalmic composition
03/21/1991WO1991003244A1 Composition for percutaneous administration
03/21/1991WO1991003241A1 Pharmaceutical preparation binding with gastric acid
03/21/1991WO1991003240A1 Methods of preventing and reducing the size of striae distensae lesions
03/21/1991WO1991003239A1 Utilization of anticomplements for the treatment of periodontosis
03/21/1991WO1991003238A1 Utilization of glutamic acid or gum-arabic as anticomplements
03/21/1991WO1991003234A1 Drug containing matrix
03/21/1991WO1991003233A1 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs
03/21/1991WO1991003232A1 Anti-inflammatory active ingredients for cosmetic preparations
03/21/1991WO1991003146A2 Method of dissolving cholesterol-rich calculi with short chain halogenated organic solvents and cosolvents
1 ... 7359 7360 7361 7362 7363 7364 7365 7366 7367 7368 7369 7370 7371 7372 7373 7374 7375 7376 7377 7378 7379 ... 7860